[Editors' note: In November, Medtech Insight sat down with Asia-based regulatory experts to discuss updates from the region in the second Medtech Associations Regulatory Networking event, sponsored by Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professional Association (ARPA). The main takeaways from the conversation on Singapore and updates from the recent APACMed regulatory track, are detailed below. The first part of this month's conversation covered Malaysia.]
Broad-scale medtech regulatory change is under way in Singapore, as part of a program designed to speed highly-innovative products into...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?